WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 9 fonti

Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin medicación

La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20% de estos pacientes

Raccontata daapnews.comindependent.co.ukcnn.comoglobo.globo.comelespectador.compbs.orgsciencealert.comlanacion.com.argizmodo.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
lanacion.com.arStai leggendo16 h fa

Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin…

La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20% de estos pacientes

originale

Timeline cronologica

  1. giovedì 28 maggio 2026·apnews.com

    Experimental hepatitis B drug may offer 'functional cure' for some patients

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.

  2. giovedì 28 maggio 2026·independent.co.uk

    Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

elespectador.com
1 g fa

Hay avances esperanzadores hacia una cura funcional de la hepatitis B, que afecta a millones

Un nuevo tratamiento mostró avances muy prometedores hacia una cura funcional de la hepatitis B crónica, que afecta a millones de personas.

Leggi questa versione → originale
apnews.com1 g fa

Experimental hepatitis B drug may offer 'functional cure' for some patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.

Leggi questa versione → originale
pbs.org1 g fa

Hepatitis B drug may offer 'functional cure' for some patients

Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that the immune system could keep it in…

Leggi questa versione → originale
independent.co.uk1 g fa

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

Leggi questa versione → originale
sciencealert.com1 g fa

New Drug Offers 'Functional Cure' For Dangerous Liver Virus

WASHINGTON (AP) – A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional cure," researchers reported Thursday.

Leggi questa versione → originale
  • giovedì 28 maggio 2026·independent.co.uk

    FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

    New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

  • giovedì 28 maggio 2026·cnn.com

    Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients | CNN

    A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers…

  • giovedì 28 maggio 2026·oglobo.globo.com

    Nova injeção elimina completamente hepatite B em 20% dos pacientes

    Tratamentos atuais proporcionam cura para apenas cerca de 1% das pessoas que vivem com o vírus de forma crônica

  • giovedì 28 maggio 2026·elespectador.com

    Hay avances esperanzadores hacia una cura funcional de la hepatitis B, que afecta a millones

    Un nuevo tratamiento mostró avances muy prometedores hacia una cura funcional de la hepatitis B crónica, que afecta a millones de personas.

  • giovedì 28 maggio 2026·pbs.org

    Hepatitis B drug may offer 'functional cure' for some patients

    Researchers reported Thursday that in two international studies, about 1 in 5 patients given the experimental drug for six months saw their virus reduced to levels low enough that…

  • venerdì 29 maggio 2026·sciencealert.com

    New Drug Offers 'Functional Cure' For Dangerous Liver Virus

    WASHINGTON (AP) – A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional…

  • venerdì 29 maggio 2026·lanacion.com.ar

    Avance clave contra la hepatitis B: por primera vez, un tratamiento logra una remisión sostenida sin medicación

    La mayoría de las personas se recupera de la infección, pero esta representa grandes riesgos para quienes no lo hacen; un fármaco experimental podría ser una solución para el 20%…

  • venerdì 29 maggio 2026·gizmodo.com

    Experimental Drug May Offer a 'Functional Cure' for Some People with Chronic Hepatitis B

    Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment.